BALAMINES Stock Overview
Engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for BALAMINES from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Balaji Amines Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,781.45 |
| 52 Week High | ₹2,710.00 |
| 52 Week Low | ₹1,711.40 |
| Beta | 1.22 |
| 1 Month Change | -14.44% |
| 3 Month Change | -20.75% |
| 1 Year Change | -33.33% |
| 3 Year Change | -52.17% |
| 5 Year Change | 332.23% |
| Change since IPO | 6,168.31% |
Recent News & Updates
Here's Why Balaji Amines (NSE:BALAMINES) Can Manage Its Debt Responsibly
Dec 31
Here's What's Concerning About Balaji Amines' (NSE:BALAMINES) Returns On Capital
Oct 23Recent updates
Here's Why Balaji Amines (NSE:BALAMINES) Can Manage Its Debt Responsibly
Dec 31Here's What's Concerning About Balaji Amines' (NSE:BALAMINES) Returns On Capital
Oct 23The Balaji Amines Limited (NSE:BALAMINES) Analyst Just Cut Their Revenue Forecast By 15%
Aug 13Balaji Amines Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Aug 11At ₹2,409, Is It Time To Put Balaji Amines Limited (NSE:BALAMINES) On Your Watch List?
Jul 30Balaji Amines (NSE:BALAMINES) Is Increasing Its Dividend To ₹11.00
Jun 20Balaji Amines (NSE:BALAMINES) Has A Pretty Healthy Balance Sheet
Jun 12There Are Reasons To Feel Uneasy About Balaji Amines' (NSE:BALAMINES) Returns On Capital
Apr 05Downgrade: What You Need To Know About The Latest Balaji Amines Limited (NSE:BALAMINES) Forecasts
Feb 15Analysts Are More Bearish On Balaji Amines Limited (NSE:BALAMINES) Than They Used To Be
Nov 24Are Investors Undervaluing Balaji Amines Limited (NSE:BALAMINES) By 39%?
Jul 14Investors Shouldn't Overlook The Favourable Returns On Capital At Balaji Amines (NSE:BALAMINES)
Jun 22Balaji Amines' (NSE:BALAMINES) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 09Is Now The Time To Look At Buying Balaji Amines Limited (NSE:BALAMINES)?
Apr 05Investors Shouldn't Overlook Balaji Amines' (NSE:BALAMINES) Impressive Returns On Capital
Mar 15These Analysts Think Balaji Amines Limited's (NSE:BALAMINES) Sales Are Under Threat
Feb 15With EPS Growth And More, Balaji Amines (NSE:BALAMINES) Makes An Interesting Case
Feb 08Balaji Amines (NSE:BALAMINES) Seems To Use Debt Quite Sensibly
Dec 25Why The 42% Return On Capital At Balaji Amines (NSE:BALAMINES) Should Have Your Attention
Dec 02Should You Think About Buying Balaji Amines Limited (NSE:BALAMINES) Now?
Oct 14Does Balaji Amines (NSE:BALAMINES) Deserve A Spot On Your Watchlist?
Sep 27Is Balaji Amines (NSE:BALAMINES) A Risky Investment?
Jul 13Is There Now An Opportunity In Balaji Amines Limited (NSE:BALAMINES)?
Jun 16The Trend Of High Returns At Balaji Amines (NSE:BALAMINES) Has Us Very Interested
May 06Does Balaji Amines (NSE:BALAMINES) Deserve A Spot On Your Watchlist?
Apr 12We Think Balaji Amines (NSE:BALAMINES) Can Stay On Top Of Its Debt
Mar 28Should You Investigate Balaji Amines Limited (NSE:BALAMINES) At ₹2,901?
Mar 14Is Balaji Amines (NSE:BALAMINES) Using Too Much Debt?
Sep 28Does Balaji Amines (NSE:BALAMINES) Deserve A Spot On Your Watchlist?
Aug 23Is It Too Late To Consider Buying Balaji Amines Limited (NSE:BALAMINES)?
Jul 28Is Balaji Amines (NSE:BALAMINES) A Risky Investment?
Jun 25Shareholder Returns
| BALAMINES | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -8.6% | 1.2% | 1.8% |
| 1Y | -33.3% | 2.5% | 18.0% |
Return vs Industry: BALAMINES underperformed the Indian Chemicals industry which returned 2.1% over the past year.
Return vs Market: BALAMINES underperformed the Indian Market which returned 17.4% over the past year.
Price Volatility
| BALAMINES volatility | |
|---|---|
| BALAMINES Average Weekly Movement | 4.4% |
| Chemicals Industry Average Movement | 5.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: BALAMINES has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: BALAMINES's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 1,084 | Dundurapu Reddy | www.balajiamines.com |
Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene glycol, and propylene carbonate.
Balaji Amines Limited Fundamentals Summary
| BALAMINES fundamental statistics | |
|---|---|
| Market cap | ₹57.73b |
| Earnings (TTM) | ₹2.02b |
| Revenue (TTM) | ₹15.29b |
28.6x
P/E Ratio3.8x
P/S RatioIs BALAMINES overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BALAMINES income statement (TTM) | |
|---|---|
| Revenue | ₹15.29b |
| Cost of Revenue | ₹8.41b |
| Gross Profit | ₹6.88b |
| Other Expenses | ₹4.86b |
| Earnings | ₹2.02b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 62.24 |
| Gross Margin | 44.98% |
| Net Profit Margin | 13.19% |
| Debt/Equity Ratio | 0.8% |
How did BALAMINES perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield17%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 04:26 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Balaji Amines Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kameswari V. S. Chavali | FirstCall Research |
| null null | K.R. Choksey Shares & Securities Private Ltd. |